Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on Offer for Subscription

22 Jun 2021 17:22

RNS Number : 7588C
Amati AIM VCT PLC
22 June 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

AMATI AIM VCT PLC

LEI: 213800HAEDBBK9RWCD25

22 June 2021

Update on Offer for Subscription

Following the announcement made on 12 April 2021, the Board of Amati AIM VCT PLC (the "Company") has discussed the size and structure of the proposed offer for subscription (the "Offer") with the Company's investment manager. Having considered the deployment of funds over the last six months and the current pipeline of investment opportunities, the Company is seeking to raise £30 million over a 12 month period from the date of publication of the prospectus related to the Offer. Initially, subscriptions will be accepted for the 2021/2022 tax year only.

The Directors will also have discretion to utilise an over-allotment facility of up to £30 million, either in whole or in part. This facility will only be utilised if sufficient Qualifying Investments have been made from the initial proceeds of the Offer and the investment manager has identified further investment opportunities. In this event, the Company may also accept applications in respect of the 2022/2023 tax year.

Subject to certain conditions, the Board intends to open the Offer to existing shareholders for a limited period prior to opening the Offer to new investors.

The prospectus, which will contain the full details and terms and conditions of the Offer, will be available from www.amatiglobal.com as soon as the Offer is launched, which is expected to be at the end of July 2021. A further announcement will be made when the prospectus is available.

Further information

For further information please contact Samantha Dalby on 0131 503 9115 or email: info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKKAAFXFEFA
Date   Source Headline
1st Aug 20232:51 pmRNSTransaction in Own Shares
1st Aug 20239:47 amRNSTotal Voting Rights
24th Jul 20232:45 pmRNSDirector/PDMR Shareholding
21st Jul 20234:31 pmRNSIssue of Equity - DRIS
21st Jul 20233:41 pmRNSNet Asset Value(s)
14th Jul 20235:28 pmRNSNet Asset Value(s)
11th Jul 20234:46 pmRNSTransaction in Own Shares
7th Jul 20235:30 pmRNSNet Asset Value(s)
6th Jul 202312:47 pmRNSTransaction in Own Shares
4th Jul 202310:10 amRNSNet Asset Value(s)
3rd Jul 202310:56 amRNSTotal Voting Rights
26th Jun 202311:43 amRNSNet Asset Value(s)
23rd Jun 20234:41 pmRNSTransaction in Own Shares
19th Jun 20239:14 amRNSNet Asset Value(s)
15th Jun 20232:34 pmRNSResult of AGM
9th Jun 20235:18 pmRNSNet Asset Value(s)
2nd Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 202310:32 amRNSTotal Voting Rights
26th May 20234:01 pmRNSNet Asset Value(s)
22nd May 20232:11 pmRNSNet Asset Value(s)
15th May 20235:06 pmRNSTransaction in Own Shares
15th May 20239:36 amRNSNet Asset Value(s)
5th May 20233:56 pmRNSNet Asset Value(s)
3rd May 202311:17 amRNSNet Asset Value(s)
2nd May 20238:55 amRNSTotal Voting Rights
26th Apr 20231:14 pmRNSTransaction in Own Shares
24th Apr 20234:15 pmRNSNet Asset Value(s)
18th Apr 202311:44 amRNSTransaction in Own Shares
18th Apr 20237:01 amRNSDividend Declaration
18th Apr 20237:00 amRNSAnnual Financial Report
14th Apr 20233:26 pmRNSNet Asset Value(s)
6th Apr 20235:01 pmRNSNet Asset Value(s)
4th Apr 20239:25 amRNSNet Asset Value(s)
3rd Apr 202311:52 amRNSTransaction in Own Shares
3rd Apr 20239:36 amRNSTotal Voting Rights
24th Mar 20235:18 pmRNSNet Asset Value(s)
17th Mar 20235:04 pmRNSNet Asset Value(s)
17th Mar 20232:56 pmRNSCompliance with Market Abuse Regulation
15th Mar 20232:47 pmRNSTransaction in Own Shares
14th Mar 202311:34 amRNSTransaction in Own Shares
10th Mar 20235:26 pmRNSNet Asset Value(s)
8th Mar 202312:43 pmRNSTransaction in Own Shares
1st Mar 20234:34 pmRNSNet Asset Value(s)
1st Mar 20239:06 amRNSTotal Voting Rights
24th Feb 20235:31 pmRNSNet Asset Value(s)
24th Feb 202311:57 amRNSTransaction in Own Shares
21st Feb 202311:07 amRNSTransaction in Own Shares
20th Feb 202311:18 amRNSNet Asset Value(s)
14th Feb 20233:15 pmRNSTransaction in Own Shares
10th Feb 20234:04 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.